Heart failure - An epidemic of uncertain proportions

New England Journal of Medicine

Volumn 347, Issue 18, 2002, Pages 1442-1444

  Redfield, Margaret M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOVASCULAR RISK; DEMOGRAPHY; EDITORIAL; EPIDEMIC; EPIDEMIOLOGICAL DATA; HEALTH CARE SYSTEM; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SURVIVAL;

DISEASE OUTBREAKS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; MORTALITY; SURVIVORS; UNITED STATES;

EID: 0037206359     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe020115     Document Type: Editorial

References (16)

1. Braunwald E. Shattuck Lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-9.
2. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-402.
3. Senni M, Redfield MM. Heart failure with preserved systolic function: A different natural history? J Am Coll Cardiol 2001;38:1277-82.
4. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-9.
5. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: Trends in incidence and survival over a 10-year period. Arch Intern Med 1999;159:29-34.
6. Mosterd A, D'Agostino RB, Silbershatz H, et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999;340:1221-7.
7. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9. [Erratum, Hypertension 1996;27:1192.]
8. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease: Mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-90.
9. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
10. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-Year results from 37 WHO MONICA project populations: Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353:1547-57.
11. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial i0nfarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002;136:341-8.
12. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.
13. Ho KKK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
14. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000;102:1126-31.
15. Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J 1998;135:367-72.
16. National Population Projections. Washington, D.C.: Census Bureau, 2002. (Accessed October 10, 2002, at http://www.census.gov/population/www/projections/natproj.html.)